Colin Hislop, Senior VP, Cardiovasc. Prod at Anthera Pharmaceuticals Inc (ANTH), bought 500 shares at $4.80 ($2K) on 2010-08-18, disclosed to the SEC on 2010-08-20.
Open-market purchase of $2k ANTH by Senior VP, Cardiovasc. Prod. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.80 | 200 | $960 | 40.0% |
| 2 | $4.80 | 300 | $1K | 60.0% |
| Total | $4.80 avg | 500 | $2K | 100% |
| Filing → |
| ANTH | SELL | 2015-11-18 | $66K | — | Filing → |
| ANTH | SELL | 2015-11-12 | $27K | — | Filing → |
| ANTH | SELL | 2012-02-06 | $246K | — | Filing → |